to
Close
close

Member Login


User ID  
Password

Media Releases

25 July, 2017

Today, the Royal College of Pathologists of Australasia (RCPA) provides a new position statement to offer guidance on thyroid function testing in the Australian and New Zealand context in the adult population. The position statement provides a summary of the epidemiology of thyroid disease and the technical aspects of testing, and outlines recommendations for thyroid function testing for diagnosis and monitoring of thyroid disease.

4 July, 2017

The Royal College of Pathologists of Australasia (RCPA) would like to clarify its formal policy on non-medical and nurse practitioner requesting of pathology, as approved in February 2013. The RCPA does not endorse or have any partnership or alliance with any programs in relation to the non-medical requesting of pathology tests.

10 May, 2017

The Royal College of Pathologists of Australasia (RCPA) strongly supports the Federal Government's new measure, 'Pathology Approved Collection Centres - strengthening Compliance', which was announced last night as part of the 2017-2018 Federal Budget.

16 November, 2016

The Royal College of Pathologists of Australasia (RCPA) has today released a new position statement, detailing its guidelines for a defined list of pathology tests that are required to monitor diabetes effectively. The RCPA recommends an annual monitoring care set for adult stable diabetes which includes tests for the following: Creatinine, cholesterol, triglycerides; HDL cholesterol; Microalbumin; and HbA1c. Diabetes prevention programs such as this, aims to assist in limiting the number of potentially preventable hospitalisations for chronic conditions linked to diabetes. By defining guidelines for the healthcare profession to monitor adult stable diabetes, the RCPA hopes to improve patient care and lead to better controls and lower complication rates.

16 November, 2016

The Royal College of Pathologists of Australasia (RCPA) has today released a new position statement and comprehensive checklist which outlines patients’ expectations of pathologists and the pathology profession. The checklist was developed in close collaboration with the RCPA’s dedicated Lay Advisory Committee, and will be utilised to develop and revise future curricula for the training of new pathologists. The collaborative approach of the RCPA and the Lay Advisory Committee is the first of its kind and has identified consumers’ expectations of pathologists, which is a completely new approach.

16 November, 2016

The Royal College of Pathologists of Australasia (RCPA) has announced a new position statement, outlining its recommendations on the requesting, testing and reporting of serum tumour markers, specifically related to the testing of serum specimens (not urine, tissue or cells). The appropriate use of tumour marker testing is complex and the new guidelines have been created to reduce the risk of patient harm which may occur when testing is performed inappropriately. The recommendations do not include markers such as prostate specific antigen or hormones, although the principles described with respect to tumour marker testing and the reporting of results may still apply.

16 November, 2016

Today, pathologists, scientists and laboratories around the globe - Australia, New Zealand, Hong Kong, Singapore, Malaysia, the UK, Ireland, the USA, Canada, and South Africa – gathered to celebrate International Pathology Day (IPD) 2016.

13 May, 2016

A re-elected Turnbull Government is committed to ensuring Australians continue to have affordable access to pathology services.

22 February, 2016

The Royal College of Pathologists of Australasia (RCPA) strongly condemns a report from the Grattan Institute's health program director Stephen Duckett, which was released as an analysis of the way the Federal Government pays for pathology tests.

15 December, 2015

The Royal College of Pathologists of Australasia (RCPA) has warned that removal of the Bulk Billing Incentive for Pathology services, announced by the Federal Government today, is expected to have a detrimental impact on healthcare delivery in Australia and harm patients. The cuts will take effect from 01 July 2016 and will equate to $650 million over four years for Pathology and Diagnostic Imaging.

Displaying results 1-10 (of 89)
  < 1 2 3 4 5 6 7 8 9  >